Ovarian cancer in France: Trends in incidence, mortality and survival, 1980-2012

Gynecologic Oncology

Volumn 139, Issue 2, 2015, Pages 324-329

  Trétarre, Brigitte ^a   Molinié, Florence ^b   Woronoff, Anne Sophie ^c   Bossard, Nadine ^d   Bessaoud, Faiza ^a   Marrer, Emilie ^e   Grosclaude, Pascale ^f   Guizard, Anne Valérie ^g   Delafosse, Patricia ^h   Bara, Simona ⁱ   Velten, Michel ^j   Lapôtre Ledoux, Bénédicte ^k   Ligier, Karine ^l   Léone, Nathalie ^m   Arveux, Patrick ⁿ   Uhry, Zoé ^d,o  

^a Registre des Tumeurs de l'Hérault ^*  (France)

^b Registre Général des Cancers de Loire Atlantique et Vendée   (France)

^c Registre des cancers du Doubs   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e Registre des Cancers du Haut Rhin   (France)

^f Registre des Cancers du Tarn   (France)

^g Registre Tumeurs Digestives Calvados   (France)

^h Registre des Cancers de l'Isère   (France)

ⁱ Centre Hospitalier Public du Cotentin   (France)

^j Registre des cancers du Bas Rhin   (France)

^k Registre du Cancer de la Somme   (France)

^l Registre general des cancers de Lille et de sa region   (France)

^m Registre Général des Cancers en Limousin   (France)

ⁿ Registre des cancers du sein et des cancers gynécologiques de Côte d Or   (France)

^o INSTITUT DE VEILLE SANITAIRE   (France)

more..

Author keywords

Histological type; Incidence; Mortality; Ovarian cancer; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; FRANCE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SEX CORD TUMOR; SURVIVAL TIME; TREND STUDY; TUMOR BIOPSY; AGED; CARCINOMA; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; REGISTER; SEX CORD-GONADAL STROMAL TUMORS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; FRANCE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; REGISTRIES; SEX CORD-GONADAL STROMAL TUMORS; SURVIVAL RATE;

EID: 84952323488     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.09.013     Document Type: Article

References (40)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, and et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.11 2013 Lyon, France International Agency for Research on Cancer
2. K.A. Lowe, V.M. Chia, A. Taylor, C. O'Malley, M. Kelsh, M. Mohamed, and et al. An international assessment of ovarian cancer incidence and mortality Gynecol. Oncol. 130 2013 107 114
3. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study Lancet Oncol. 15 2014 23 34
4. J.T. Quirk, and N. Natarajan Ovarian cancer incidence in the United States, 1992-1999 Gynecol. Oncol. 97 2005 519 523
5. F. Binder-Foucard, N. Bossard, P. Delafosse, A. Belot, A.S. Woronoff, and L. Remontet Cancer incidence and mortality in France over the 1980-2012 period: solid tumors Rev. Epidemiol. Sante Publique 62 2014 95 108
6. M.P. Perme, J. Stare, and J. Esteve On estimation in relative survival Biometrics 68 2012 113 120
7. S. Bashir, and J. Esteve Analysing the difference due to risk and demographic factors for incidence or mortality Int. J. Epidemiol. 29 5 2001 878 884
8. R.M. Merrill Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States Ann. Epidemiol. 16 2006 880 887
9. D.W. Cramer The epidemiology of endometrial and ovarian cancer Hematol. Oncol. Clin. North Am. 26 2012 1 12
10. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2011. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
11. Engholm G, Ferlay J, Christensen N, Johannesen TB, Khan S, Milter MC, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.0 (17.12.2014). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu, access on 16 May 2015.
12. K. Doufekas, and A. Olaitan Clinical epidemiology of epithelial ovarian cancer in the UK Int. J. Womens Health 6 2014 537 545
13. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C.M. Magnusson, and et al. Risk factors for invasive epithelial ovarian cancer: results from a swedish case-control study Am. J. Epidemiol. 156 2002 363 373
14. A. Tavani, E. Ricci, C. La Vecchia, M. Surace, G. Benzi, F. Parazzini, and et al. Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer Int. J. Epidemiol. 29 2000 799 802
15. V. Beral, R. Doll, C. Hermon, R. Peto, and G. Reeves Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls Lancet 371 2008 303 314
16. M.S. Rice, M.A. Murphy, and S.S. Tworoger Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis J. Ovarian Res. 5 2012 13
17. F. Chiaffarino, F. Parazzini, A. Decarli, S. Franceschi, R. Talamini, M. Montella, and et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer Gynecol. Oncol. 97 2005 318 322
18. M.T. Goodman, and H.L. Howe Descriptive epidemiology of ovarian cancer in the United States, 1992-1997 Cancer 97 2003 2615 2630
19. C. Huchon Etat des lieux des hystérectomies en France Réalités en Gynécologie-Obstétrique. 167 2013 1 4
20. A. Gervaise Anastomose Tubo-tubaire par coelioscopie ou laparotomie Rapport d'évaluation technique 2008 Haute Autorité de Santé Saint Denis La Plaine, France 50
21. Collaborative Group On Epidemiological Studies Of Ovarian C Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies Lancet 2015
22. V. Beral, K. Gaitskell, C. Hermon, K. Moser, G. Reeves, and R. Peto Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies Lancet Oncol. 13 2012 946 956
23. L.J. Schouten, C. Rivera, D.J. Hunter, D. Spiegelman, H.O. Adami, A. Arslan, and et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies Cancer Epidemiol. Biomark. Prev. 17 2008 902 912
24. J. Zhang, A.M. Ugnat, K. Clarke, and Y. Mao Ovarian cancer histology-specific incidence trends in Canada 1969-1993: age-period-cohort analyses Br. J. Cancer 81 1999 152 158
25. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2011. Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014. Available at: www.cdc.gov/uscs. Accessed on 16 May 2015.
26. Y.C. Chiang, C.A. Chen, C.J. Chiang, T.H. Hsu, M.C. Lin, S.L. You, and et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan J. Gynecol. Oncol. 24 2013 342 351
27. L. Elit, S.J. Bondy, Z. Chen, and L. Paszat A tale of two time periods: ovarian cancer trends in Ontario Curr. Oncol. 14 2007 57 60
28. L.A. Baldwin, B. Huang, R.W. Miller, T. Tucker, S.T. Goodrich, I. Podzielinski, and et al. Ten-year relative survival for epithelial ovarian cancer Obstet. Gynecol. 120 2012 612 618
29. Z. Berkowitz, S.H. Rim, and L.A. Peipins Characteristics and survival associated with ovarian cancer diagnosed as first cancer and ovarian cancer diagnosed subsequent to a previous cancer Cancer Epidemiol. 35 2011 112 119
30. C.L. Kosary FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin. Surg. Oncol. 10 1994 31 46
31. L. Yang, A. Klint, M. Lambe, R. Bellocco, T. Riman, K. Bergfeldt, and et al. Predictors of ovarian cancer survival: a population-based prospective study in Sweden Int. J. Cancer 123 2008 672 679
32. C.M. Nagle, C.J. Bain, A.C. Green, and P.M. Webb The influence of reproductive and hormonal factors on ovarian cancer survival Int. J. Gynecol. Cancer 18 2008 407 413
33. H.S. Bae, H.J. Kim, J.H. Hong, J.K. Lee, N.W. Lee, and J.Y. Song Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis J. Ovarian Res. 7 2014 41
34. M.M. Protani, C.M. Nagle, and P.M. Webb Obesity and ovarian cancer survival: a systematic review and meta-analysis Cancer Prev. Res. (Phila) 5 2012 901 910
35. H. Mahdi, S. Kumar, A.R. Munkarah, M. Abdalamir, M. Doherty, and R. Swensen Prognostic impact of marital status on survival of women with epithelial ovarian cancer Psycho-Oncology 22 2013 83 88
36. R.E. Bristow, M.A. Powell, N. Al-Hammadi, L. Chen, J.P. Miller, P.Y. Roland, and et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status J. Natl. Cancer Inst. 105 2013 823 832
37. NIH Consensus Conference Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer JAMA 273 1995 491 497
38. S.S. Buys, E. Partridge, A. Black, C.C. Johnson, L. Lamerato, C. Isaacs, and et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial J. Am. Med. Assoc. 305 2011 2295 2303
39. O. Solheim, D.M. Gershenson, C.G. Trope, E. Rokkones, C.C. Sun, H. Weedon-Fekjaer, and et al. Prognostic factors in malignant ovarian germ cell tumours (the Surveillance, Epidemiology and End Results experience 1978-2010) Eur. J. Cancer 50 2014 1942 1950
40. O. Solheim, J. Kaern, C.G. Trope, E. Rokkones, A.A. Dahl, J.M. Nesland, and et al. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009) Gynecol. Oncol. 131 2013 330 335